Clozapine for dopaminergic-induced paraphilias in Parkinson's disease.
Fernandez
H H
HH
Department of Neurology, Boston University School of Medicine, Boston Veterans Administration Medical Center, Massachusetts, USA.
Durso
R
R
D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002230:Carbidopa / Q000008:administration & dosage / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D010262:Paraphilic Disorders / Q000139:chemically induced* / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000008:administration & dosage / Q000009:adverse effects*
D014150:Antipsychotic Agents; D010479:Pergolide; D003024:Clozapine; D002230:Carbidopa